Persistent URL of this record https://hdl.handle.net/1887/3184644
Documents
-
- Download
- e000530.full
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors
- All authors
- Naing, A.; Gainor, J.F.; Gelderblom, H.; Forde, P.M.; Butler, M.O.; Lin, C.C.; Sharma, S.; Olza, M.O. de; Varga, A.; Taylor, M.; Schellens, J.H.M.; Wu, H.Q.; Sun, H.Y.; Silva, A.P.; Faris, J.; Mataraza, J.; Cameron, S.; Bauer, T.M.
- Date
- 2020-01-01
- Volume
- 8
- Issue
- 1